Neuroimaging as a New Diagnostic Modality in Amyotrophic Lateral Sclerosis

Esther Verstraete, Bradley R. Foerster

Research output: Contribution to journalReview article

Abstract

Amyotrophic lateral sclerosis (ALS) is characterized by progressive degeneration of upper and lower motor neurons, with variable involvement of extramotor brain regions. Currently, there are no established objective markers of upper motor neuron and extramotor involvement in ALS. Here, we review the potential diagnostic value of advanced neuroimaging techniques that are increasingly being used to study the brain in ALS. First, we discuss the role of different imaging modalities in our increasing understanding of ALS pathogenesis, and their potential to contribute to objective upper motor neuron biomarkers for the disease. Second, we discuss the challenges to be overcome and the required phases of diagnostic test development to translate imaging technology to clinical care. We also present examples of multidimensional imaging approaches to achieve high levels of diagnostic accuracy. Last, we address the role of neuroimaging in clinical therapeutic trials. Advanced neuroimaging techniques will continue to develop and offer significant opportunities to facilitate the development of new effective treatments for ALS.

Original languageEnglish (US)
Pages (from-to)403-416
Number of pages14
JournalNeurotherapeutics
Volume12
Issue number2
DOIs
StatePublished - Apr 1 2015

Fingerprint

Amyotrophic Lateral Sclerosis
Neuroimaging
Motor Neurons
Motor Neuron Disease
Brain
Routine Diagnostic Tests
Biomarkers
Clinical Trials
Technology

Keywords

  • ALS
  • Biomarker
  • Diagnostic testing
  • MRI
  • Neuroimaging
  • PET

ASJC Scopus subject areas

  • Pharmacology
  • Clinical Neurology
  • Pharmacology (medical)

Cite this

Neuroimaging as a New Diagnostic Modality in Amyotrophic Lateral Sclerosis. / Verstraete, Esther; Foerster, Bradley R.

In: Neurotherapeutics, Vol. 12, No. 2, 01.04.2015, p. 403-416.

Research output: Contribution to journalReview article

Verstraete, Esther ; Foerster, Bradley R. / Neuroimaging as a New Diagnostic Modality in Amyotrophic Lateral Sclerosis. In: Neurotherapeutics. 2015 ; Vol. 12, No. 2. pp. 403-416.
@article{8afaf3d7e19d438d8a9ec2df0d5ffb65,
title = "Neuroimaging as a New Diagnostic Modality in Amyotrophic Lateral Sclerosis",
abstract = "Amyotrophic lateral sclerosis (ALS) is characterized by progressive degeneration of upper and lower motor neurons, with variable involvement of extramotor brain regions. Currently, there are no established objective markers of upper motor neuron and extramotor involvement in ALS. Here, we review the potential diagnostic value of advanced neuroimaging techniques that are increasingly being used to study the brain in ALS. First, we discuss the role of different imaging modalities in our increasing understanding of ALS pathogenesis, and their potential to contribute to objective upper motor neuron biomarkers for the disease. Second, we discuss the challenges to be overcome and the required phases of diagnostic test development to translate imaging technology to clinical care. We also present examples of multidimensional imaging approaches to achieve high levels of diagnostic accuracy. Last, we address the role of neuroimaging in clinical therapeutic trials. Advanced neuroimaging techniques will continue to develop and offer significant opportunities to facilitate the development of new effective treatments for ALS.",
keywords = "ALS, Biomarker, Diagnostic testing, MRI, Neuroimaging, PET",
author = "Esther Verstraete and Foerster, {Bradley R.}",
year = "2015",
month = "4",
day = "1",
doi = "10.1007/s13311-015-0347-9",
language = "English (US)",
volume = "12",
pages = "403--416",
journal = "Neurotherapeutics",
issn = "1933-7213",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Neuroimaging as a New Diagnostic Modality in Amyotrophic Lateral Sclerosis

AU - Verstraete, Esther

AU - Foerster, Bradley R.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Amyotrophic lateral sclerosis (ALS) is characterized by progressive degeneration of upper and lower motor neurons, with variable involvement of extramotor brain regions. Currently, there are no established objective markers of upper motor neuron and extramotor involvement in ALS. Here, we review the potential diagnostic value of advanced neuroimaging techniques that are increasingly being used to study the brain in ALS. First, we discuss the role of different imaging modalities in our increasing understanding of ALS pathogenesis, and their potential to contribute to objective upper motor neuron biomarkers for the disease. Second, we discuss the challenges to be overcome and the required phases of diagnostic test development to translate imaging technology to clinical care. We also present examples of multidimensional imaging approaches to achieve high levels of diagnostic accuracy. Last, we address the role of neuroimaging in clinical therapeutic trials. Advanced neuroimaging techniques will continue to develop and offer significant opportunities to facilitate the development of new effective treatments for ALS.

AB - Amyotrophic lateral sclerosis (ALS) is characterized by progressive degeneration of upper and lower motor neurons, with variable involvement of extramotor brain regions. Currently, there are no established objective markers of upper motor neuron and extramotor involvement in ALS. Here, we review the potential diagnostic value of advanced neuroimaging techniques that are increasingly being used to study the brain in ALS. First, we discuss the role of different imaging modalities in our increasing understanding of ALS pathogenesis, and their potential to contribute to objective upper motor neuron biomarkers for the disease. Second, we discuss the challenges to be overcome and the required phases of diagnostic test development to translate imaging technology to clinical care. We also present examples of multidimensional imaging approaches to achieve high levels of diagnostic accuracy. Last, we address the role of neuroimaging in clinical therapeutic trials. Advanced neuroimaging techniques will continue to develop and offer significant opportunities to facilitate the development of new effective treatments for ALS.

KW - ALS

KW - Biomarker

KW - Diagnostic testing

KW - MRI

KW - Neuroimaging

KW - PET

UR - http://www.scopus.com/inward/record.url?scp=84940002145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940002145&partnerID=8YFLogxK

U2 - 10.1007/s13311-015-0347-9

DO - 10.1007/s13311-015-0347-9

M3 - Review article

C2 - 25791072

AN - SCOPUS:84940002145

VL - 12

SP - 403

EP - 416

JO - Neurotherapeutics

JF - Neurotherapeutics

SN - 1933-7213

IS - 2

ER -